Trial · NCT05955313
Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia
NCT05955313, Phase 2, Recruiting, Medical University of Lublin
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia. Trials, record NCT05955313. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05955313
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia
- NCT number
- NCT05955313
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 300 participants, estimated
- Lead sponsor
- Medical University of Lublin
- Conditions
- Vulvodynia, Naltrexone, Quality of Life
- Interventions
- Naltrexone Hydrochloride
- First posted
- 2023-07-21
- Last updated
- 2023-07-21
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Treatment effectiveness - change in pain intensity | from pre-treatment values (VISIT 2) to end of treatment values (VISIT 4) assessed for 4 months | measured by 11-point NRS scale based on spontaneously experienced vulvar and vaginal pain and during vaginal penetration |
| Primary | Treatment effectiveness - change in type and severity of pain | from pre-treatment values (VISIT 2) to end of treatment values (VISIT 4) assessed for 4 months | measured by McGill Questionnaire (SF-MPQ) |
| Primary | Treatment effectiveness - change in emotional functioning | from pre-treatment values (VISIT 2) to end of treatment values (VISIT 4) assessed for 4 months | Beck Depression Inventory (BDI-II) |
| Primary | Patient's satisfaction | from pre-treatment values (VISIT 2) to end of treatment values (VISIT 4) assessed for 4 months | measured by 11-point Lickert scale |
| Secondary | Treatment tolerability | throughout the treatment period (from VISIT 2 to VISIT 4) assessed for 4 months | Assessment of the tolerability of LDN therapy based on the assessment of side effects and adverse events |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05955313
GET https://conductscience.org/api/trials/v1/NCT05955313/registered